A new sustained-release microsphere formulation of exenatide, known as DA-3091, has shown promise in managing obesity, diabetes, and nonalcoholic fatty liver disease, offering effective metabolic control with less frequent dosing, potentially improving patient compliance
A su vez, contiene carnitina, sustancia que ayuda a mejorar el rendimiento y a producir un ahorro de glucgeno importante en el deportista
Approval of these drugs from the Defense Health Agency hinges on a few factors, which you can learn more about below
In studies with rats and mice, Saxenda and medicines that work like Saxenda caused thyroid tumors, including thyroid cancer
Jacob SW, Herschler R: Dimethyl sulfoxide after twenty years